Innocens BV leverages IBM Technology to Develop an AI Solution to help detect potential sepsis events in high-risk newborns

XenTegra Canada Inc.

Let's Search

Let's Chat

Request Information

Innocens BV leverages IBM Technology to Develop an AI Solution to help detect potential sepsis events in high-risk newborns

IBM's technology plays a crucial role in Innocens BV's AI solution for detecting potential sepsis events in high-risk newborns. Read this case study to learn how IBM's Watson Studio helps make groundbreaking innovations.

View In New Tab

Home
Contact Us
Fair Use
The material on this site is provided for educational and informational purposes. All photos that haven't been taken by us have either been purchased, used with permission, credited and linked back to their original sources or believed to be public domain. It is believed that this constitutes a `fair use` of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have an interest in using the included information for research and educational purposes. If you wish to use copyrighted material from this site for purposes of your own that go beyond `fair use`, you must obtain permission from the copyright owner.

The full experience is only one step away!

XenTegra Canada Inc. is ready to help!

Please confirm your email address!

Innocens BV leverages IBM Technology to Develop an AI Solution to help detect potential sepsis events in high-risk newborns